Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
That number landed below the 25% target that Novo Nordisk had projected, causing brief concern among investors, but it still represents one of the largest weight loss outcomes ever achieved with a pharmacological intervention
Trulicitys manufacturer pursued approval specifically for type 2 diabetes management rather than weight loss
Liraglutide, sold by Novo Nordisk as Victoza and Saxenda, is a drug used for the treatment of type 2 diabetes and obesity
Obesity: the protein leverage hypothesis
Documented dose ranges: Route notes: Intramuscular injection (deltoid, gluteal) is the most commonly cited route in community protocols
US$ 22.98
US$ 24.25
US$ 22.76
US$ 25.45
US$ 27.16
US$ 25.67
US$ 21.66
